Condition
Lyme Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Lyme Disease clinical trials that are recruiting, at sites in 4 countries (most in United States (8), Switzerland (1), Canada (1)). By phase: Phase 1/2 (1), Phase 3 (1). The most active sponsors are National Institutes of Health Clinical Center (CC) (3), Children's National Research Institute (2). There are also 65 NIH-funded research projects on Lyme Disease, with $53.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 65NIH research projects
- 4Countries
Newest Lyme Disease clinical trials
All recruiting trials (10)
-
Fifth dose of the 6‑valent OspA Lyme vaccine (VLA15)
This test gives a fifth dose of the VLA15 Lyme vaccine to people age 7 and older who already got four doses to see if it is safe and boosts immune protection.
-
Exploring pregnancy and parenting experiences in individuals with Lyme disease
This study looks at how having Lyme disease affects pregnancy and parenting experiences for those diagnosed with the condition.
-
Assessing immune response in children with Lyme disease
This study is testing a new blood test to see how children's immune systems respond to Lyme disease to help doctors diagnose it earlier and better.
-
Assessing neurodevelopmental outcomes in infants exposed to Lyme disease during pregnancy
This study is trying to see how being exposed to Lyme disease during pregnancy affects the brain development of babies from birth to 18 months.
-
Understanding how human skin reacts to tick bites
This study is testing how healthy adults' skin reacts to bites from certain ticks to better understand the immune response and help develop ways to resist tick bites.
-
Registry and biorepository for rheumatic diseases
This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.
-
Monitoring central nervous system infections in Denmark
This study is looking at how community-acquired central nervous system infections, like meningitis and encephalitis, affect adults in Denmark to better understand their symptoms, treatments, and recovery outcomes.
-
Registry for patients with rare diseases
This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.
-
Evaluation and treatment of patients with Lyme disease
This study is trying to understand and treat people with active Lyme disease by looking at their medical history, symptoms, and responses to approved medications.
-
Assessment of patients with suspected post-treatment Lyme disease syndrome
This study is testing if people who still have symptoms after being treated for Lyme disease might still have the bacteria causing those symptoms, to help understand their ongoing issues better.
NIH-funded research (newest 40 of 65)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Understanding why some people have ongoing symptoms after Lyme disease
A long-term study follows people diagnosed with acute Lyme disease to see who develops persistent symptoms and why, with care from a team of Lyme experts.
-
CSF Protein Map in Post-Treatment Lyme Disease
A short study to map proteins in spinal fluid of people who had Lyme disease and still feel sick after standard treatment, to understand what’s going on.
-
Lyme disease vaccine research aimed at preventing infection
Researchers are developing a Lyme disease vaccine by studying how the immune system responds to Borrelia burgdorferi and testing vaccine approaches to prevent illness.
-
Lyme disease brain health: tracking brain signals and blood clues after treatment
This study follows people with early Lyme disease and compares them to healthy volunteers to see how the brain and blood markers change over a year after starting antibiotics.
-
Lyme disease symptoms lingering after treatment may be driven by special bacterial fragments
A human-friendly look at a study exploring why some Lyme patients keep symptoms after antibiotics and whether tiny fragments from the bacteria are to blame.
-
Understanding Lyme disease immune signals to predict recovery after antibiotics
A research project at MIT aims to find immune biomarkers that tell which Lyme patients will recover after standard antibiotics and who might have lasting symptoms.
-
Imaging Lyme disease with special PET tracers
A new imaging tool using PET probes is being developed to visualize Lyme disease in people affected by Borrelia burgdorferi sensu lato.
-
Understanding how Lyme disease bacteria adapt to hosts at the genetic level
Scientists are studying how the Lyme disease bacterium changes its genes to thrive in ticks and mammals, to uncover how it causes infection.
-
Microbiology of Post-Treatment Lyme Disease Syndrome in Lyme Arthritis
This project looks at how different strains of the bacteria that cause Lyme disease might influence lingering symptoms after treatment in people with Lyme arthritis.
-
Immunology of lingering Lyme symptoms after treatment
This grant explores why some people continue to feel pain and fatigue after Lyme disease and how their immune systems might drive these lingering symptoms.
-
PTLDS: Understanding why some Lyme patients stay sick after treatment
A large study following people with early Lyme disease to learn why some continue to have symptoms after standard antibiotics.
-
Persistent symptoms after Lyme disease: following patients from diagnosis to recovery
A nationwide team will follow people diagnosed with acute Lyme disease over time to understand who develops lingering symptoms and why, with the goal of better tests and treatments.
-
Antibody markers that may predict lingering Lyme symptoms after treatment
This project looks at specific autoantibodies tied to host lipids to see if they can indicate who might developPost-Treatment Lyme Disease Syndrome (PTLDS) after antibiotics.
-
Defining how a Bb protein helps Lyme disease bacteria evade the immune system
Researchers are studying how a protein from the Lyme disease bacteria helps it hide from the immune system, with the goal of preventing infection.
-
Understanding Post-Treatment Lyme Disease: What Predicts PTLD and How to Identify At-Risk Patients
This NIH grant looks at why some people recover after Lyme treatment while others develop lingering symptoms, and aims to create a clinical score to identify those at higher risk.
-
Regulatory network of Lyme disease bacteria
A study to understand how the Lyme disease bacteria controls its genes as it moves between ticks and mammals, which could lead to better prevention and treatment.
-
How the Lyme bacteria get into the brain and spinal cord
Researchers will learn how the Lyme disease bacterium Borrelia burgdorferi enters the brain and spinal fluid using mouse models to help people with neurologic Lyme disease.
-
Multivalent saRNA Lyme Vaccine for Broad Protection
A new RNA-based vaccine aims to protect people against multiple Lyme disease bacteria using a single low-dose shot.
-
How wild birds help Lyme bacteria survive
This project learns how wild birds' immune systems allow Lyme disease bacteria to persist and spread, which could help people at risk from tick bites.
-
How the Lyme disease bacterium controls its harmful genes
Researchers are mapping how the Lyme bacterium turns on and off the genes that help it survive in ticks and cause infection in people.
-
How the Lyme bacteria change a surface protein to hide from the immune system
This project looks at how the Lyme disease bacteria swap parts of a surface protein to avoid immune attack, with the goal of helping people affected by Lyme disease.
-
PlzA protein and how Lyme bacteria survive in ticks and mammals
Researchers will look at how a bacterial protein called PlzA helps Lyme bacteria live in ticks and mammals to better protect people at risk of Lyme disease.
-
Mapping immune responses to Lyme disease bacteria
This study is looking at how certain parts of the Lyme disease bacteria can help our immune system recognize and fight it better, which could lead to better vaccines and treatments for people with Lyme disease.
-
Creating a new vaccine adjuvant to improve Lyme disease vaccines
This study is testing a new way to make Lyme disease vaccines work better by using a special ingredient that helps boost the immune response, so people can have stronger protection against Lyme disease.
-
Understanding the Immune System in Post-Treatment Lyme Disease Syndrome
This project aims to understand how the immune system behaves differently in people who continue to have symptoms after Lyme disease treatment compared to those who fully recover.
-
Understanding Lingering Symptoms After Lyme Disease Treatment
This project aims to understand why some people continue to feel unwell after being treated for early Lyme disease.
-
Understanding Persistent Symptoms After Lyme Disease
This project aims to understand why some people continue to feel sick after being treated for Lyme disease by following them closely from the time they are first diagnosed.
-
Giving long-lasting Lyme protection to wild white-footed mice
Researchers aim to create a one-time genetic immunization for white-footed mice to cut the number of infected ticks and lower Lyme disease risk for people.
-
Bacterial cell-wall pieces and lingering Lyme symptoms
This project tests whether unique fragments of the Lyme bacterium's cell wall cause ongoing joint and nerve symptoms in people who had Lyme disease.
-
Unusual bacterial fragments that may cause long-lasting Lyme symptoms
This work looks at whether pieces of the Lyme bacterium left behind after antibiotics cause ongoing joint pain in people who had Lyme disease.
-
Brain scans and blood tests for lingering neurologic symptoms after Lyme disease
This project uses brain imaging and blood tests to follow people treated for early Lyme disease who still have ongoing neurologic or cognitive symptoms over one year.
-
Single-step, more accurate blood test for Lyme disease
This project is creating a single-step blood test that is easier to use and less likely to give false positives so people get faster, clearer Lyme diagnoses.
-
New Imaging Tools for Lyme Disease
This project aims to create special imaging agents that can help doctors better find and understand Lyme disease in people.
-
Understanding how a component of Lyme disease bacteria affects symptoms
This study is looking at how a part of the Lyme disease bacteria might cause ongoing symptoms, like arthritis, in people even after they've been treated with antibiotics, and it aims to help us understand why some patients still feel unwell.
-
Understanding how Lyme Disease Bacteria Adapt to Survive
This project explores how the bacteria that cause Lyme disease change and adapt to successfully live inside both ticks and people.
-
Understanding Auto-antibodies in Post-Treatment Lyme Disease Syndrome
This research looks at specific antibodies in people with Lyme disease to understand why some develop long-lasting symptoms after treatment.
-
A quick test for Babesia and Lyme disease
This project is creating a fast, easy-to-use test to find Babesia parasites and Lyme disease antibodies directly from a patient's sample.
-
Understanding how genetic factors affect the immune response in Lyme disease.
This study is looking at how the bacteria that causes Lyme disease can change its surface to hide from our immune system, focusing on a specific protein called VlsE, which could help us find new ways to treat Lyme disease.
-
Understanding Why Some People Get Long-Term Symptoms After Lyme Disease Treatment
This research aims to discover why some individuals continue to experience symptoms after being treated for Lyme disease, while others fully recover.
-
Understanding how Lyme disease bacteria invade the nervous system
This study is looking at how the bacteria that cause Lyme disease can enter the brain and spinal fluid, and how different types of mice respond to this infection, to help find better treatments for people with serious neurological issues related to Lyme disease.
Related topics
Quick answers
How many Lyme Disease clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (8 trials), Switzerland (1 trial), Canada (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.